FDA Inspection 1050097 — Biomet, Inc.

Biomet, Inc. — FEI 1825034

The FDA completed an inspection of Biomet, Inc. on Apr 24, 2018 in Warsaw, IN. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 11 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Apr 24, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Compliance: Devices
Location
Warsaw, IN (United States)

Citations

IDCFRDescription
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
311921 CFR 820.75(b)Lack/Inad procedure-Monitoring/Control of Validated Proces
312021 CFR 820.80(a)Lack of or inadequate procedures - Acceptance activities
313021 CFR 820.100(a)Lack of or inadequate procedures
323321 CFR 820.72(a)Calibration, Inspection, etc. Procedures Lack of or Inadequ
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
367821 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate
368021 CFR 820.70(a)Process control procedures, Lack of or inadequate procedures
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures
54121 CFR 820.70(c)Environmental control Lack of or inadequate procedures
54621 CFR 820.75(a)Lack of or inadequate process validation

Need the full FDA record for Biomet, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.